SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-18-185690
Filing Date
2018-06-06
Accepted
2018-06-06 16:39:25
Documents
5

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 TO SCHEDULE TO d573786dsctota.htm SC TO-T/A 59685
2 EX-99.(A)(1)(XXIII) d573786dex99a1xxiii.htm EX-99.(A)(1)(XXIII) 24156
3 EX-99.(A)(1)(XXIV) d573786dex99a1xxiv.htm EX-99.(A)(1)(XXIV) 14225
4 GRAPHIC g573786s1.jpg GRAPHIC 29597
5 GRAPHIC g573786s2.jpg GRAPHIC 3403
  Complete submission text file 0001193125-18-185690.txt   143450
Mailing Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
Business Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
TAKEDA PHARMACEUTICAL CO LTD (Filed by) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: SC TO-T/A

Mailing Address ROMEINSE STRAAT 12 BOX 2, 3001 LEUVEN C9 0000000
Business Address ROMEINSE STRAAT 12 BOX 2, 3001 LEUVEN C9 0000000 34918060946
TiGenix NV (Subject) CIK: 0001581987 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9
Type: SC TO-T/A | Act: 34 | File No.: 005-89730 | Film No.: 18884195
SIC: 2834 Pharmaceutical Preparations